FreeMind proudly supports Kisaco’s Onco Cell Therapy Summit.

---

How do we improve efficacy and drive down the cost of cell therapies?

We will explore the potential for improved safety and reduced costs for next generation therapies at the Onco Cell Therapy Summit on November 17-18 in Boston.

With more than 70 cell therapy developing companies already registered, you can network with Century Therapeutics, IN8bio, Legend Biotech, Sanofi, and many more. Find out more by downloading the agenda here.

We have four tracks of content, so plenty of insight to choose from, but here are some key sessions I thought would be of interest to you:

• Overcome severe and potentially life-threatening toxicities and drive past complex patient specific manufacturing with NK cell therapies with Nkarta and Artiva Biotherapeutics
• Improve efficiency of development by implementing the newest manufacturing technologies into your process with a critical automatization deep dive with John Tomtishen, Director of Manufacturing and Technical Operations, Legend Biotech
• Transition supply chains to fit the off the shelf model to identify optimal donors, and scale up effectively with a presentation from Emilie Gauthy, R&D Manager CMC and Process Development, Celyad Oncology

With the US borders opening on November 8, we can’t wait to welcome the industry back to in-person events. You can secure your place by registering here.

Looking forward to seeing you in Boston!

Best regards,

Freddie Metherell

Portfolio Manager, Life Sciences | Kisaco Research